Table 1.
Characteristic | All patients (N = 11 308) | Patients from clinics with beds ≤19 (N = 5396) | Patients from hospitals with beds ≥20 (N = 5912) |
---|---|---|---|
Age‐y | 73.1 ± 9.9 | 73.2 ± 9.8 | 73.1 ± 9.9 |
<75 y‐no. (%) | 5804 (51.3) | 2764 (51.2) | 3040 (51.4) |
≥75 y‐no. (%) | 5504 (48.7) | 2632 (48.8) | 2872 (48.6) |
Female sex‐no. (%) | 4306 (38.1) | 2125 (39.4) | 2181 (36.9) |
Height‐cm | 160.2 ± 9.9 | 160.0 ± 10.1 | 160.3 ± 9.7 |
Body weight‐kg | 60.9 ± 12.6 | 61.2 ± 12.6 | 60.7 ± 12.7 |
Body weight‐no. (%) | |||
≤50 kg | 2209 (19.5) | 1011 (18.7) | 1198 (20.3) |
>50 kg | 8081 (71.5) | 3887 (72.0) | 4194 (70.9) |
Unknown | 1018 (9.0) | 498 (9.2) | 520 (8.8) |
BMI‐kg/m2 | 23.7 ± 3.8 | 23.9 ± 3.6 | 23.6 ± 3.9 |
BMI‐no. (%) | |||
<18.5 | 615 (5.4) | 228 (4.2) | 387 (6.6) |
18.5 to <25 | 5348 (47.3) | 2495 (46.2) | 2853 (48.3) |
25 to <30 | 2493 (22.0) | 1230 (22.8) | 1263 (21.4) |
≥30 | 483 (4.3) | 232 (4.3) | 251 (4.3) |
Unknown | 2369 (20.9) | 1211 (22.4) | 1158 (19.6) |
Creatinine clearance‐mL/min | 67.7 ± 28.9 | 68.5 ± 31.2 | 67.0 ± 26.5 |
Creatinine clearance‐no. (%) | |||
<15 mL/min | 3 (0.03) | 2 (0.04) | 1 (0.02) |
15 to < 30 mL/min | 312 (2.8) | 131 (2.4) | 181 (3.1) |
30 to < 50 mL/min | 2382 (21.1) | 1099 (20.4) | 1283 (21.7) |
50 to < 80 mL/min | 4792 (42.4) | 2278 (42.2) | 2514 (42.5) |
≥80 mL/min | 2895 (25.6) | 1428 (26.5) | 1467 (24.8) |
Unknown | 924 (8.2) | 458 (8.5) | 466 (7.9) |
CHADS2 score | 2.2 ± 1.3 | 2.1 ± 1.3 | 2.3 ± 1.3 |
CHADS2 score‐no. (%) | |||
0 | 985 (8.7) | 498 (9.2) | 487 (8.2) |
1 | 2802 (24.8) | 1439 (26.7) | 1363 (23.1) |
2 | 3400 (30.1) | 1701 (31.5) | 1699 (28.7) |
3 | 2206 (19.5) | 951 (17.6) | 1255 (21.2) |
4 | 1294 (11.4) | 532 (9.9) | 762 (12.9) |
5 | 514 (4.5) | 223 (4.1) | 291 (4.9) |
6 | 107 (0.9) | 52 (1.0) | 55 (0.9) |
Baseline comorbidities‐no. (%) | |||
Hypertension | 8405 (74.3) | 4094 (75.9) | 4311 (72.9) |
Diabetes mellitus | 2523 (22.3) | 1182 (21.9) | 1341 (22.7) |
Previous stroke or transient ischemic attack | 2675 (23.7) | 995 (18.4) | 1680 (28.4) |
Congestive heart failure | 2826 (25.0) | 1351 (25.0) | 1475 (24.9) |
Switch from other anticoagulants‐no. (%) | |||
No | 5291 (46.8) | 2380 (44.1) | 2911 (49.2) |
Yes | 6017 (53.2) | 3016 (55.9) | 3001 (50.8) |
Warfarin | 3960 (35.0) | 1909 (35.4) | 2051 (34.7) |
Dabigatran | 1688 (14.9) | 915 (17.0) | 773 (13.1) |
Other | 369 (3.3) | 192 (3.6) | 177 (3.0) |
Plus‐minus values are means ±SD.